Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd-$

Dr. Agarwal's Eye Hospital Ltd has announced the fixation of record date for the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Ltd and Dr. Agarwal's Health Care Ltd, with the record date set as November 18, 2026. The scheme involves the exchange of shares between the two companies, with eligible shareholders receiving 23 shares of Dr. Agarwal's Health Care Ltd for every 2 shares of Dr. Agarwal's Eye Hospital Ltd held as on the record date.

Dr Agarwals Eye Hospital Ltd-$

Dr. Agarwal's Eye Hospital Ltd has fixed November 18, 2026 as the record date for determining eligible shareholders to receive consideration shares in the amalgamation with Dr. Agarwal's Health Care Ltd.

Dr Agarwals Eye Hospital Ltd-$

Dr. Agarwal's Eye Hospital Ltd has announced the outcome of its board meeting, where it has approved the effectiveness of the scheme of amalgamation between Dr. Agarwal's Eye Hospital Ltd and Dr. Agarwal's Health Care Ltd. The scheme will become effective from November 1, 2026, and the record date for allotment of consideration shares has been fixed as November 18, 2026.

Dr Agarwals Eye Hospital Ltd-$

Dr. Agarwals Eye Hospital Ltd has submitted a compliance certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018, for the period from July 1, 2026, to September 30, 2026, confirming that shares dematerialized and rematerialized during this period have been listed on the stock exchanges and that the company has taken necessary actions as per the regulation.

Dr Agarwals Eye Hospital Ltd-$

Dr. Agarwals Eye Hospital Ltd has received sanction from the Hon'ble NCLT, Chennai bench, for the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and their respective shareholders and creditors.

Dr Agarwals Eye Hospital Ltd-$

Dr. Agarwal's Eye Hospital Ltd has announced the closure of its trading window for all designated persons and their immediate relatives, effective September 30, 2026, due to the finalization and publication of unaudited financial results for the quarter and half year ending September 30, 2026.

Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd has launched the World's First dedicated Pinhole Pupilloplasty (PPP) Centre at its flagship facility in Chennai, India. The centre will focus on delivering advanced clinical treatments using the Pinhole Pupilloplasty technique, developed by Dr. Amar Agarwal, to address complex corneal disorders.

Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd-$ has published a newspaper advertisement for the 32nd Annual General Meeting (AGM) of the company, which will be held on September 09, 2026. The notice includes details of the record date, e-voting instructions, and other necessary information for the AGM. The company has also made its annual report and other documents available on its website.

Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd has announced its 32nd Annual General Meeting (AGM) to be held on September 09, 2026, through Video Conferencing (VC) / Other Audio Visual Means (OAVM. The AGM will consider and adopt the audited financial statement for the financial year ended March 31, 2026, and declare a final dividend of INR 4.00 per equity share (40%) for the financial year 2025-26.

Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd has announced the record date for the payment of final dividend for the financial year 2025-26, and has scheduled its 32nd Annual General Meeting (AGM) for September 09, 2026.

Dr Agarwals Eye Hospital Ltd-$

Dr. Agarwal's Eye Hospital Ltd has submitted its annual report for the financial year 2025-26, along with the notice convening the 32nd Annual General Meeting (AGM) of the company. The report highlights the company's focus on clinical excellence, innovation, and expansion, including the adoption of Pinhole Pupilloplasty (PPP), a pioneering procedure in ophthalmology. The company has also emphasized its organic growth strategy and plans to expand its presence in Tamil Nadu and underserved markets.

Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd-$ has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Invesco Mutual Fund.

Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd reappoints cost auditors M/s. B Y & Associates for FY 2026-27, and releases unaudited financial results for Q1 FY 2026-27.

Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results and re-appointing M/s. B Y & Associates as the Cost Auditors for the financial year 2026-27.

Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd-$ announced the outcome of its Board Meeting held on August 03, 2026, where it considered and approved unaudited financial results for the quarter ended June 30, 2026, along with the re-appointment of Cost Auditors for the financial year 2026-27.

Dr Agarwals Eye Hospital Ltd-$

Dr Agarwals Eye Hospital Ltd has scheduled a board meeting on August 3, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026.